Tag Archive | "CSL"

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


The term ‘top pharma’ can relate to the top pharmaceutical companies or the top 10 or 50… Read the full story

CSL

Tags: , ,


CSL is a top pharmaceutical company based in Melbourne, Australia Read the full story

$950m share buy back for blood specialist CSL

Tags: , , , ,


Vaccine maker and blood products specialist CSL in $950m share buyback. Read the full story

CSL: Protecting patients globally with vaccines and plasma products

Tags: , , ,


CSL is a large speciality biopharmaceutical company developing and manufacturing plasma products and vaccines to treat and protect patients worldwide. Read the full story

CSL M&A deals 2005-2013

Tags: , ,


CSL has announced only 1 M&A deal since 2005, with the acquisition of Zenyth Therapeutics Read the full story

CSL: Partnering activity 2005-2013

Tags: , , ,


CSL is a global pharma company active in the development of vaccines and plasma proteins with a prime focus on influenza vaccine – partnering, collaborative R&D and licensing activity of CSL is reviewed here.

Read the full story

CSL: Company profile

Tags: , ,


CSL, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

Partnering Agreements with CSL

Tags: , , , , , , ,


This report provides all the information you require to better understand CSL and its partnering interests and activities over the past seven years. Read the full story

Leader in plasma protein therapies created through Grifols/Talecris combination

Tags: , , ,


It is a rare event to see a multi-billion dollar acquisition take place involving a company outside the bigpharma top 50. Read the full story

Merck inks domestic rights to Afluria from CSL

Tags: , ,


The six-year agreement with CSL Biotherapies, a division of CSL, calls for Merck to market Afluria in the United States, where it was approved by the Food and Drug Administration in 2007, starting next year. CSL will make the vaccine and maintain marketing and distribution rights in the rest of the world.

cpbannerad300x150new2gif
biotech-china-300x150jpg
anglonordiccupart300x150jpg
RSS Feed Linked In Twitter

Latest Tweets

cabannerad300x150new4gif
biotech-china-300x150jpg
biowales-300x150-enjpg